Stay updated with breaking news from Device Exemption. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its PulseSelect™ Pulsed Field Ablation (PFA) System...
22.02.2023 - REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) - Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the 'Company'), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and ...
This article looks at Investigational Device Exemptions (IDE) and their use in clinical studies.
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval - read this article along with other careers information, tips and advice on BioSpace
Get latest articles and stories on Business at LatestLY. SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions. Business News | MedAlliance SELUTION SLR is the First DEB to Receive Coronary De Novo IDE Approval, Its Fourth FDA IDE DEB Approval.